arrow
V

Viviana Moschese

University of Rome Tor Vergata
H指数:34
被引数:3,565

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Malignancies in inborn errors of immunity: a retrospective-prospective study on a large Italian cohort of pediatric and adult patients

免疫缺陷病中的恶性肿瘤:一项针对意大利大型儿科和成人患者队列的回顾性与前瞻性研究

2026-11-110
OA
Pre-vaccination immune signatures of children with inborn errors of immunity associate with COVID-19 vaccine response

免疫功能不全儿童的预接种疫苗免疫特征与COVID-19疫苗应答相关

2026-04-240
OAAI
IgE to cyclophilin Bet v 7 triggers mast cell activation and mediates cross-reactivity with Ara h 18 in children with seasonal allergic rhinitis

季节性过敏性鼻炎患儿中,对环孢菌素Bet v 7的IgE可触发肥大细胞活化,并介导与Ara h 18的交叉反应性。

2026-03-040
OAAI
Italian pediatric experts' consensus statement on diagnosis and management of primary atopic disorders

意大利儿科专家关于原发性过敏性疾病诊断与管理的共识声明

2025-11-020
OAAI
Towards personalized vaccines
2024-10-031
OAAI
Inverse association between the molecular spreading of IgE to grass pollen and the IgE response to Dermatophagoides pteronyssinus among children with seasonal allergic rhinitis

季节性过敏性鼻炎儿童中IgE向草花粉的分子扩散与IgE对屋尘螨的反应之间的负相关

2024-10-010
OAAI
IPINeT Ped-unPAD Study: Goals, Design, and Preliminary Results
2024-07-240
OAAI
IgE to cyclophilins in pollen-allergic children: Epidemiologic, clinical, and diagnostic relevance of a neglected panallergen

花粉过敏儿童中亲环素的IgE: 被忽视的泛过敏原的流行病学,临床和诊断相关性

2024-06-012
OAAI
IgE to cross-reactive carbohydrate determinants (CCD) in childhood: Prevalence, risk factors, putative origins

儿童IgE与交叉反应性碳水化合物决定因素 (CCD): 患病率,危险因素,推定起源

2024-01-173
OA
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study

Dupilumab治疗6-11岁儿童特应性皮炎: 一项多中心、现实生活研究

2022-08-2744
OAAI
Vaccinations in Children and Adolescents Treated With Immune-Modifying Biologics: Update and Current Developments

用免疫修饰生物制剂治疗的儿童和青少年的疫苗接种: 更新和当前发展

2022-06-011
OAAI